As of the latest SEC filings, ALUMIS INC. (ALMS) is held by 182 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $66,711,312.09 in market value, representing a significant portion of its portfolio.
Funds holding ALUMIS INC. (ALMS)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- ALMS
- CIK:
- 0001847367
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $66,711,312.09 | 3,028,203 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.05% | $36,821,294.48 | 1,671,416 | Mar 31, 2026 | May 28, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.24% | $26,185,364.69 | 1,188,623 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.02% | $19,962,109.99 | 906,133 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.05% | $16,741,326.09 | 678,061 | Apr 30, 2026 | Jun 26, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.31% | $16,682,811.00 | 561,900 | Feb 28, 2026 | Apr 24, 2026 |
|
PRJIX
T. Rowe Price New Horizons Fund, Inc.
|
MF | T. Rowe Price | 0.12% | $14,698,856.60 | 667,220 | Mar 31, 2026 | May 28, 2026 |
|
IWN
iShares Russell 2000 Value ETF
|
ETF | BlackRock / iShares | 0.10% | $12,937,932.61 | 587,287 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.03% | $12,278,358.88 | 413,552 | Feb 28, 2026 | Apr 24, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.14% | $11,683,786.74 | 530,358 | Mar 31, 2026 | May 28, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.06% | $11,463,576.21 | 386,109 | Feb 28, 2026 | Apr 24, 2026 |
|
OSCAX
Invesco Main Street Small Cap Fund
|
MF | Invesco | 0.47% | $10,446,383.67 | 474,189 | Mar 31, 2026 | May 28, 2026 |
|
PSBMX
SmallCap Fund
|
MF | Independent / Boutique | 0.50% | $10,406,835.00 | 421,500 | Apr 30, 2026 | Jun 25, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.13% | $8,718,824.78 | 293,662 | Feb 27, 2026 | Apr 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.05% | $8,314,565.74 | 280,046 | Feb 28, 2026 | Apr 28, 2026 |
|
FBTIX
Fidelity Advisor Biotechnology Fund
|
MF | Fidelity | 0.43% | $8,162,514.00 | 330,600 | Apr 30, 2026 | Jun 26, 2026 |
|
PRDSX
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund
|
MF | T. Rowe Price | 0.09% | $7,250,073.00 | 329,100 | Mar 31, 2026 | May 28, 2026 |
|
RVT
ROYCE SMALL-CAP TRUST, INC.
|
CEF | Independent / Boutique | 0.24% | $5,348,134.98 | 242,766 | Mar 31, 2026 | May 21, 2026 |
|
FESM
Fidelity Enhanced Small Cap ETF
|
ETF | Fidelity | 0.12% | $5,116,004.87 | 232,229 | Mar 31, 2026 | May 26, 2026 |
|
IHE
iShares U.S. Pharmaceuticals ETF
|
ETF | BlackRock / iShares | 0.50% | $4,990,918.53 | 226,551 | Mar 31, 2026 | May 22, 2026 |
|
XPH
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF
|
ETF | State Street (SPDR) | 1.60% | $4,937,517.81 | 224,127 | Mar 31, 2026 | May 28, 2026 |
|
VHCIX
VANGUARD HEALTH CARE INDEX FUND
|
ETF | Vanguard | 0.02% | $4,759,930.49 | 160,321 | Feb 28, 2026 | Apr 28, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $4,375,504.37 | 147,373 | Feb 28, 2026 | Apr 24, 2026 |
|
RPMIX
Royce Small-Cap Fund
|
MF | Independent / Boutique | 0.23% | $4,156,972.88 | 188,696 | Mar 31, 2026 | May 21, 2026 |
|
DWAS
Invesco Dorsey Wright SmallCap Momentum ETF
|
ETF | Invesco | 0.99% | $3,834,611.95 | 129,155 | Feb 28, 2026 | Apr 28, 2026 |
Advertisement (320x50)